Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Seizure Frequency

Time frame: Baseline up to Week 28

Number of Participants With (All Causality) Adverse Events (AEs) and Serious Adverse Events (SAEs)

Counts of participants who had treatment-emergent adverse events (TEAEs), defined as newly occurring or worsening after first dose. Participants with multiple occurrences of an AE within a category were counted once within the category.

Time frame: Baseline up to Week 28

Number of Participants With Laboratory Test Values of Potential Clinical Importance

Pre-defined criteria were established for each laboratory test (hematology, blood chemistry and urinalysis) to define the values that would be identified as of potential clinical importance.

Time frame: Baseline up to Week 28